Codes / ICD10CM / T83.723A

T83.723A Exposure of implanted urethral bulking agent into urethra, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Exposure of implanted urethral bulking agent into urethra, initial encounter

Summary

Exposure of implanted urethral bulking agent into the urethra refers to a complication where a urethral bulking agent, used in procedures for stress urinary incontinence or urethral reconstruction, becomes visible or protrudes through the urethral wall. This can lead to discomfort, infection, or other complications requiring medical evaluation and management.

Causes

The condition may result from factors such as improper surgical technique, infection, inflammation, or the body's reaction to the bulking agent material. Over time, degradation of the implant, migration, or mechanical failure may also contribute to exposure.

Risk Factors

  • Prior urethral surgeries involving bulking agents
  • Infections or chronic inflammation
  • Physical activity placing stress on the urethral area
  • Smoking or conditions that impair healing
  • Individual sensitivity to foreign materials

Symptoms

  • Urethral discharge or bleeding
  • Pain or discomfort in the urethral area
  • Sensation of bulking agent visibility or protrusion
  • Pain during urination
  • Urinary symptoms, such as incontinence or urgency

Diagnosis

Diagnosis typically involves a physical examination to assess the urethral wall and bulking agent exposure. Imaging studies like ultrasound or MRI may be used to evaluate the agent's position and surrounding tissues.

Treatment Options

Treatment may include conservative measures like topical therapies or antibiotics for infection. Surgical intervention may be necessary to remove or reposition the exposed agent, depending on the severity and patient symptoms.

Prognosis and Follow-Up

Prognosis depends on the extent of exposure and response to treatment. Follow-up care is important to monitor for recurrence, infection, or other complications. Regular evaluations help ensure proper healing and functional recovery.

Complications

Potential complications include infection, urethral stricture, persistent pain, or urinary dysfunction. In severe cases, further surgical intervention may be required.

Lifestyle & Prevention

Avoid activities that strain the urethral area during recovery. Maintain good hygiene and follow post-procedure care instructions. Smoking cessation and managing chronic conditions can support healing.

When to Seek Professional Help

Seek medical attention if symptoms worsen, such as increased pain, discharge, or urinary issues. Prompt evaluation is important if signs of infection (e.g., fever, pus) or severe discomfort occur.

Tips for Medical Coders

Document the type of bulking agent, location of exposure, and whether this is the initial encounter. Include details on clinical findings, imaging results, and treatment provided to support code assignment. Ensure documentation aligns with the specific characteristics of the exposure and encounter type.

Book a walkthrough

T83.723A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.